Distinct molecular and biochemical mechanisms may underlie this association; for example, cytokines like interleukin-17 (IL-17) and tumor necrosis factor-alpha (TNF-α) are upregulated in autoimmune liver disease, driving chronic inflammation and raising graft rejection risk [12]. This evidence concerns the gene IL17A and autoimmune hepatitis.